Document Detail


Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction.
MedLine Citation:
PMID:  20610234     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Erythropoietin (EPO) has generated interest as a novel therapy after myocardial infarction (MI), but the safety and efficacy of prolonged therapy have not been studied in a large animal model of reperfused MI.
METHODS AND RESULTS: MI was induced in pigs by a 90-minute balloon occlusion of the left anterior descending coronary artery. Sixteen animals were randomized to either EPO or saline (control group). Inflammatory markers, bone marrow cell mobilization, and left ventricular function (by both echocardiography and pressure-volume measurements) were assessed at baseline, 1 and 6 weeks post-MI. EPO therapy was associated with a significant increase in hemoglobin and mononuclear counts. D-dimer and C-reactive protein levels did not differ between groups. At week 6, EPO therapy prevented further deterioration of left ventricular ejection fraction (39 +/- 2% vs. 33 +/- 1%, P < .01) and improved wall motion score index (P < .02). Histopathology revealed increased areas of viable myocardium, vascular density, and capillary-to-myocyte ratio in the EPO therapy compared with the control (all P < .05).
CONCLUSION: Prolonged EPO therapy after MI in a large animal model is safe and leads to an increase in viable myocardium, increased vascular density, and prevents further deterioration of left ventricular function. These results support future clinical studies in post-MI patients.
Authors:
Franca S Angeli; Nicolas Amabile; Sukesh Burjonroppa; Mia Shapiro; Lauren Bartlett; Yan Zhang; Renu Virmani; Kanu Chatterjee; Andrew Boyle; William Grossman; Yerem Yeghiazarians
Related Documents :
835634 - Menopause and myocardial infarction.
1800494 - Myocardial infarction in the young.
2199424 - Prophylactic use of mexiletine in the elderly with acute myocardial infarction.
11591624 - Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is ...
3748834 - Left ventricular function in isolated rheumatic mitral stenosis in children.
10728414 - Alterations in ca2+ cycling proteins and g alpha q signaling after left ventricular ass...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-04-03
Journal Detail:
Title:  Journal of cardiac failure     Volume:  16     ISSN:  1532-8414     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  579-89     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Division of Cardiology, Department of Medicine, University of California, San Francisco, CA 94143-0103, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac ...
Next Document:  Attenuation of left ventricular adverse remodeling with epicardial patching after myocardial infarct...